DO PATIENTS WITH ADVANCED CANCER WANT TO DISCUSS AND PAY FOR UNFUNDED EXPENSIVE ANTICANCER DRUGS?
conference contribution
posted on 2014-12-01, 00:00authored byLinda Mileshkin, Edward Livshin, Jeremy Lewin, Sandra Harvey, Mark Voskoboynik, Emilia Agalianos, Penelope Schofield, Alan Herschtal, Aparna Rao, Ian CollinsIan Collins, Damien Urban, George Au-Yeung, John Zalcberg
DO PATIENTS WITH ADVANCED CANCER WANT TO DISCUSS AND PAY FOR UNFUNDED EXPENSIVE ANTICANCER DRUGS?